Genetic DI Risks Webinar Presentation

Adverse Drug Interaction Risks in Genetically-Defined Subpopulations


Presented by: Maciej Czerwinski, Ph.D., Director of Sekisui XenoTech Products R&D
Originally Aired: 20 June 2016

Give Feedback